These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9778585)

  • 1. Glyceraldehyde 3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts.
    Cooper AJ; Sheu KF; Burke JR; Strittmatter WJ; Blass JP
    Dev Neurosci; 1998; 20(4-5):462-8. PubMed ID: 9778585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts.
    Mazzola JL; Sirover MA
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):95-101. PubMed ID: 12008025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts.
    Mazzola JL; Sirover MA
    J Neurochem; 2001 Jan; 76(2):442-9. PubMed ID: 11208907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyceraldehyde 3-phosphate dehydrogenase augments the intercellular transmission and toxicity of polyglutamine aggregates in a cell model of Huntington disease.
    Mikhaylova ER; Lazarev VF; Nikotina AD; Margulis BA; Guzhova IV
    J Neurochem; 2016 Mar; 136(5):1052-63. PubMed ID: 26662373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.
    Browne SE; Bowling AC; MacGarvey U; Baik MJ; Berger SC; Muqit MM; Bird ED; Beal MF
    Ann Neurol; 1997 May; 41(5):646-53. PubMed ID: 9153527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control intensity of glycolytic enzymes in ultrasonic hemolysates of erythrocytes].
    Reimann B; Küttner G; Maretzki D; Rapoport S
    Acta Biol Med Ger; 1975; 34(11-12):1777-85. PubMed ID: 135459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycolytic enzymes in different types of skeletal muscle: adaptation to exercise.
    Baldwin KM; Winder WW; Terjung RL; Holloszy JO
    Am J Physiol; 1973 Oct; 225(4):962-6. PubMed ID: 4270315
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.
    Guzhova IV; Lazarev VF; Kaznacheeva AV; Ippolitova MV; Muronetz VI; Kinev AV; Margulis BA
    Hum Mol Genet; 2011 Oct; 20(20):3953-63. PubMed ID: 21775503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts.
    Mazzola JL; Sirover MA
    J Neurosci Res; 2003 Jan; 71(2):279-85. PubMed ID: 12503091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model.
    Naseri NN; Xu H; Bonica J; Vonsattel JP; Cortes EP; Park LC; Arjomand J; Gibson GE
    J Neuropathol Exp Neurol; 2015 Jun; 74(6):527-37. PubMed ID: 25978848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the interaction site of CP12 with glyceraldehyde-3-phosphate dehydrogenase from Chlamydomonas reinhardtii. Functional consequences for glyceraldehyde-3-phosphate dehydrogenase.
    Lebreton S; Andreescu S; Graciet E; Gontero B
    FEBS J; 2006 Jul; 273(14):3358-69. PubMed ID: 16803460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.
    Cooper AJ; Sheu KR; Burke JR; Onodera O; Strittmatter WJ; Roses AD; Blass JP
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12604-9. PubMed ID: 9356496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoamide dehydrogenase in cultured human skin fibroblasts.
    Melançon SB; Dallaire L; Potier M
    Clin Chim Acta; 1978 Jul; 87(1):29-34. PubMed ID: 668142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin fibroblasts in Huntington disease.
    Goetz IE; Roberts E; Warren J
    Am J Hum Genet; 1981 Mar; 33(2):187-96. PubMed ID: 6452059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of lens glycolytic pathway by thioltransferase.
    Qiao F; Xing K; Lou MF
    Exp Eye Res; 2000 Jun; 70(6):745-53. PubMed ID: 10843779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differencies of the enzyme pattern of various strains of Ehrlich ascites tumor].
    Letnansky K
    Z Krebsforsch; 1968; 70(3):222-9. PubMed ID: 4233636
    [No Abstract]   [Full Text] [Related]  

  • 17. [Crystallization of phosphofructokinase and glyceraldehyde-3-phosphate dehydrogenase from rat muscles].
    Pechenova TM; Gulii MF; Shevtsova NF; Bekirova GO
    Ukr Biokhim Zh; 1971; 43(6):683-8. PubMed ID: 4263838
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional organization of the enzyme systems of glycolysis in muscle and nerve tissue of cephalopod molluscs and lower fishes].
    Verzhbinskaia NA
    Zh Evol Biokhim Fiziol; 1973; 8(3):260-8. PubMed ID: 4271688
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice.
    Oláh J; Klivényi P; Gardián G; Vécsei L; Orosz F; Kovacs GG; Westerhoff HV; Ovádi J
    FEBS J; 2008 Oct; 275(19):4740-55. PubMed ID: 18721135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of glycolytic enzymes at different stages of the mitotic cycle of Ehrlich tumor cells].
    Kavetskiĭ RE; Kaz'min SD
    Dokl Akad Nauk SSSR; 1974; 218(5):1233-5. PubMed ID: 4371176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.